Skip to main content

Amlodipine besylate and Olmesartran medoxomil

NDC 62332-213 · Alembic Pharmaceuticals Inc.

Generic nameAmlodipine besylate and Olmesartran medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL
Strength5; 40 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Marketing categoryANDA

Packages

62332-213-30 — 30 TABLET, FILM COATED in 1 BOTTLE (62332-213-30)

62332-213-90 — 90 TABLET, FILM COATED in 1 BOTTLE (62332-213-90)

62332-213-91 — 1000 TABLET, FILM COATED in 1 BOTTLE (62332-213-91)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-132 — Olmesartan Medoxomil, 62332-133 — Olmesartan Medoxomil, 62332-149 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-150 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-151 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-205 — Amlodipine and Valsartan, 62332-206 — Amlodipine and Valsartan, 62332-207 — Amlodipine and Valsartan, 62332-208 — Amlodipine and Valsartan, 62332-212 — Amlodipine besylate and Olmesartran medoxomil, 62332-214 — Amlodipine besylate and Olmesartran medoxomil, 62332-215 — Amlodipine besylate and Olmesartran medoxomil, 62332-755 — Amlodipine and Atorvastatin, 62332-756 — Amlodipine and Atorvastatin, 62332-757 — Amlodipine and Atorvastatin, 62332-758 — Amlodipine and Atorvastatin, 62332-759 — Amlodipine and Atorvastatin, 62332-760 — Amlodipine and Atorvastatin, 62332-761 — Amlodipine and Atorvastatin, 62332-762 — Amlodipine and Atorvastatin, +720 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels